AVBP vs AWK · $1.39B cap vs P/E 22, rev $4.65B
ArriVent BioPharma, Inc. Common Stock (AVBP) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
ArriVent BioPharma, Inc. Common Stock (AVBP) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
AVBP does not have a complete income-statement cache yet.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
AVBP currently screens at market cap $1.39B. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the AVBP and AWK stock pages for the full models.
Not investment advice.